COMPASS PATHWAYS PLC (CMPS) Stock Price, Quote, News and Overview
NASDAQ:CMPS - Nasdaq - US20451W1018 - ADR - Currency: USD
CMPS Quote, Performance and Key Statistics
4.21
-0.33 (-7.27%)
The current stock price of CMPS is 4.21 USD. In the past month the price increased by 8.79%. In the past year, price decreased by -58.68%.
CMPS Competitors/Peers
Symbol | Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 19.97 | 357.10B | ||
| AMGN | AMGEN INC | 15.29 | 162.72B | ||
| GILD | GILEAD SCIENCES INC | 23.85 | 137.00B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 1669.79 | 124.40B | ||
| REGN | REGENERON PHARMACEUTICALS | 15.34 | 76.56B | ||
| ARGX | ARGENX SE - ADR | N/A | 39.16B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | N/A | 32.32B | ||
| BNTX | BIONTECH SE-ADR | N/A | 28.77B | ||
| ONC | BEIGENE LTD-ADR | N/A | 27.25B | ||
| NTRA | NATERA INC | N/A | 21.43B | ||
| BIIB | BIOGEN INC | 8.54 | 20.49B | ||
| SMMT | SUMMIT THERAPEUTICS INC | N/A | 16.31B |
Related stock screener links
About CMPS
Company Profile
Compass Pathways Plc is an investment holding company. The company is headquartered in Altrincham, Cheshire and currently employs 186 full-time employees. The company went IPO on 2020-09-18. The firm is engaged in the development of psilocybin treatment, in which its investigational COMP360 psilocybin is administered in conjunction with psychological support, COMP360 psilocybin treatment. COMP360 is its proprietary psilocybin formulation that includes its pharmaceutical-grade polymorphic crystalline psilocybin, optimized for stability and purity. The Company’s initial focus is on treatment-resistant depression (TRD), comprising patients who are inadequately served by the current treatment paradigm. The company commenced its Phase III program evaluating its COMP360 psilocybin treatment in TRD. In addition, the Company has ongoing Phase II trials in PTSD and anorexia nervosa. The company also provides support to research institutions conducting investigator-initiated studies with COMP360 psilocybin in areas of serious unmet need.
Company Info
COMPASS PATHWAYS PLC
3Rd Floor, 1 Ashley Road
Altrincham CHESHIRE WA14 2DT GB
CEO: George Goldsmith
Employees: 186
Company Website: https://compasspathways.com/
Investor Relations: https://ir.compasspathways.com/
Phone: 17166766461
COMPASS PATHWAYS PLC / CMPS FAQ
What is the stock price of COMPASS PATHWAYS PLC today?
The current stock price of CMPS is 4.21 USD. The price decreased by -7.27% in the last trading session.
What is the ticker symbol for COMPASS PATHWAYS PLC stock?
The exchange symbol of COMPASS PATHWAYS PLC is CMPS and it is listed on the Nasdaq exchange.
On which exchange is CMPS stock listed?
CMPS stock is listed on the Nasdaq exchange.
What is the price forecast or stock price prediction for COMPASS PATHWAYS PLC stock?
16 analysts have analysed CMPS and the average price target is 21.31 USD. This implies a price increase of 406.1% is expected in the next year compared to the current price of 4.21. Check the COMPASS PATHWAYS PLC stock analysts ratings, price target forecast and up-and down grades for more detailed information.
What is COMPASS PATHWAYS PLC worth?
COMPASS PATHWAYS PLC (CMPS) has a market capitalization of 389.15M USD. This makes CMPS a Small Cap stock.
How many employees does COMPASS PATHWAYS PLC have?
COMPASS PATHWAYS PLC (CMPS) currently has 186 employees.
What are the support and resistance levels for COMPASS PATHWAYS PLC (CMPS) stock?
COMPASS PATHWAYS PLC (CMPS) has a support level at 4.2 and a resistance level at 4.33. Check the full technical report for a detailed analysis of CMPS support and resistance levels.
Should I buy COMPASS PATHWAYS PLC (CMPS) stock?
There is no straightforward answer here. It depends on your investment strategy as different types of investors will look at different aspects. In any case it is important to make an informed decision and these pages can help you forming an opinion:
- The Technical Analysis (TA) tab contains a technical analysis of CMPS, looking at technical quality and support and resistance levels
- The Fundamental Analysis (FA) tab contains a fundamental analysis of CMPS, evaluating the profitability, health, valuation and growth aspects
- COMPASS PATHWAYS PLC (CMPS) Price Target Forecast and Analysts Ratings to understand what professional analysts say.
- COMPASS PATHWAYS PLC (CMPS) Sales and EPS estimates to see what analysts future expectations are.
- COMPASS PATHWAYS PLC (CMPS) Income, Balance Sheet and Cash Flow statements to dive into the historical financials.
- COMPASS PATHWAYS PLC (CMPS) Insider and Institutional Ownership to learn about the owners and their transactions.
- COMPASS PATHWAYS PLC (CMPS) Stock Chart to make your own analysis
- COMPASS PATHWAYS PLC (CMPS) Latest news and press-releases to stay up to date.
Does COMPASS PATHWAYS PLC (CMPS) stock pay dividends?
CMPS does not pay a dividend.
When does COMPASS PATHWAYS PLC (CMPS) report earnings?
COMPASS PATHWAYS PLC (CMPS) will report earnings on 2025-02-26, after the market close.
What is the Price/Earnings (PE) ratio of COMPASS PATHWAYS PLC (CMPS)?
COMPASS PATHWAYS PLC (CMPS) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.2).
What is the Short Interest ratio of COMPASS PATHWAYS PLC (CMPS) stock?
The outstanding short interest for COMPASS PATHWAYS PLC (CMPS) is 5.78% of its float. Check the ownership tab for more information on the CMPS short interest.
CMPS Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to CMPS. When comparing the yearly performance of all stocks, CMPS is a bad performer in the overall market: 90.85% of all stocks are doing better.
CMPS Fundamental Analysis
ChartMill assigns a fundamental rating of 2 / 10 to CMPS. The financial health of CMPS is average, but there are quite some concerns on its profitability.
CMPS Financial Highlights
Over the last trailing twelve months CMPS reported a non-GAAP Earnings per Share(EPS) of -2.2. The EPS increased by 15.06% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -58.35% | ||
| ROE | -74.77% | ||
| Debt/Equity | 0.14 |
CMPS Ownership and Analysts
ChartMill assigns a Buy % Consensus number of 84% to CMPS. The Buy consensus is the average rating of analysts ratings from 16 analysts.